flow trial glp 1 Ozempic® (semaglutide injection) GLP-1 Receptor Agonists for the
Description
PMID: 36550793
Additionally studies on zinc supplementation found reductions in body weight, but only when combined with a calorie-restricted diet
Preclinical and clinical evidence suggests GLP-1 agonists may have mild mood-stabilizing properties, potentially complementing sertraline's anxiolytic effects
The framework is flexible, not a rigid diet meant to guide everyday choices across diverse lifestyles
